HAMILTON, Bermuda--(BUSINESS WIRE)--Covidien Ltd. (NYSE: COV, BSX: COV) will report second-quarter results before trading begins on April 30, 2009. The Company will hold a conference call for investors at 8:30 a.m. ET. The call can be accessed in the following ways:

• At Covidien’s website: http://investor.covidien.com
• By telephone: For both “listen-only” participants and those participants who wish to take part in the question-and-answer portion of the call, the telephone dial-in number in the U.S. is 866-356-3377. For participants outside the U.S., the dial-in number is 617-597-5392. The access code for all callers is 43316435.
• Through an audio replay: A replay of the conference call will be available beginning at 11:30 a.m. on April 30, 2009, and ending at 5:00 p.m. on May 7, 2009. The dial-in number for U.S. participants is 888-286-8010. For participants outside the U.S., the replay dial-in number is 617-801-6888. The replay access code for all callers is 96226100.

ABOUT COVIDIEN

Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines in four segments: Medical Devices, Imaging Solutions, Pharmaceutical Products and Medical Supplies. With 2008 revenue of nearly $10 billion, Covidien has more than 41,000 employees worldwide in 59 countries, and its products are sold in over 140 countries. Please visit www.covidien.com to learn more about our business.